BioCentury
ARTICLE | Finance

Elements of infrastructure

Detailing iCarbonX's to-do list after the Chinese biotech's big series A

May 9, 2016 7:00 AM UTC

With big data infrastructure creation at the top of iCarbonX's to-do list, the Shenzhen-based personalized health management company tapped Chinese internet giant Tencent Holdings Ltd. (HKSE:700) to lead its RMB1 billion ($154.4 million) series A financing.

Other investors in the series A included Zhongyuan Union Stem Cell Bioengineering Corp. (Shanghai:600645) and Tianfu Group. iCarbonX said its postmoney valuation stands at $1 billion. ...